TWiV 889: COVID-19 clinical update #110 with Dr. Daniel Griffin

April 16, 2022

In COVID-19 clinical update #110, Dr. Griffin covers hospital admissions during variant outbreaks, viral load in vaccinated and unvaccinated individuals, predictive capacity of symptoms in children, comparison of antigen tests, incidence of myocarditis after vaccination, steroids during replication phase, Paxlovid efficacy and safety, fluvoxamine, sabizabutin, colchicine, and prevalence of infection in Africa.

Click arrow to play
Download TWiV 889 (52 MB .mp3, 53 min)
Subscribe (free): Apple PodcastsGoogle PodcastsRSSemail

Become a patron of TWiV!

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to

Leave a Reply

Your email address will not be published. Required fields are marked *

3 comments on “TWiV 889: COVID-19 clinical update #110 with Dr. Daniel Griffin

  1. Rowan Langley Apr 16, 2022

    Good morning Professor Racinello,
    Good update from Daniel on the YouTube, but download links are going to TWiV 886 at the moment. Lookiy forward to 889 going up on the download so I can put it on my phone to enjoy again.

  2. Dudley Gordon Apr 16, 2022

    Dr Griffin. I am a 70 yo retired Family Physician who has fully enjoyed and learned much from both your weekly briefing and all the TWIV podcasts What is happening to Novavax in the USA. It has been approved in 39 other countries, why has it taken so long for this approval process. This protein subunit vaccine would likely be more acceptable to those hesitant to have the perceived “experimental “ RNA vaccines with very similar efficacy and severe disease prevention. I am hoping it will be approved by fall so that I may have this as a choice for my 2nd booster. Thanks so much for all the hard work you all have done and the efforts to improve and distribute public health education, Dudley Gordon. MD